A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors
A Gålne, H Almquist, M Almquist… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
[引用][C] A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine …
A Gålne, H Almquist, M Almquist, C Hindorf… - Journal of Nuclear …, 2019 - lup.lub.lu.se
A prospective observational study to evaluate the effects of long-acting somatostatin analogs on
68Ga-DOTATATE uptake in patients with neuroendocrine tumors | Lund University Publications …
68Ga-DOTATATE uptake in patients with neuroendocrine tumors | Lund University Publications …
[引用][C] A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine …
A Gålne, H Almquist, M Almquist… - Journal of Nuclear …, 2019 - portal.research.lu.se
A prospective observational study to evaluate the effects of long-acting somatostatin analogs
on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors — Lund University Skip …
on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors — Lund University Skip …
A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors …
A Gålne, H Almquist, M Almquist, C Hindorf… - Journal of Nuclear …, 2019 - europepmc.org
Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
[PDF][PDF] A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine …
A Gålne, H Almquist, M Almquist, C Hindorf… - J Nucl …, 2019 - Soc Nuclear Med
Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
[HTML][HTML] A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine …
A Gålne, H Almquist, M Almquist, C Hindorf… - Journal of Nuclear …, 2019 - ncbi.nlm.nih.gov
Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors
A Gålne, H Almquist, M Almquist… - Journal of nuclear …, 2019 - pubmed.ncbi.nlm.nih.gov
Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …